Sandostatin LAR 30mg Injection
Inclusive of all taxes
Free Express Cold-Chain Delivery
Temperature-controlled dispatch across India within 4 to 24 hours.
Order through WhatsAppFinancial Assistance Available
Contact our oncology support team to check your eligibility for manufacturer patient assistance programs (PAP) for Sandostatin LAR 30mg Injection.
About this medicine
Sandostatin LAR 30mg Injection (Octreotide acetate (30mg))is a prescription oncology medicine. Below is educational product information — follow your doctor's advice for dose and use.
Sandostatin LAR 30mg Injection is used in the treatment of acromegaly, carcinoid tumors, and bleeding esophageal varices. It is also used to prevent complications following surgery of the pancreas.This medicine is generally given by a healthcare professional. You should not self-administer this medicine at home. Your doctor will decide the dose and how often you should take them. You should use it regularly to get the most benefit from the medicine. Do not stop using the medicine even if you feel better unless the doctor tells you so.Using this medicine may cause few common side effects such as diarrhea, abdominal pain, nausea, constipation, flatulence, and headache. Let your doctor know if any of these side effects do not go away or get worse. Before using this medicine, inform your doctor if you have problems with your liver. You should also tell your doctor all the other medicines you are taking.
Quick Facts
Generic Name
Octreotide acetate (30mg)
Dosage Form
Injection
Prescription Status
Doctor's Rx Required
What if you miss a dose?
If you miss a dose of Sandostatin LAR 30mg Injection, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.\n
Uses of Sandostatin LAR 30mg Injection
Side Effects of Sandostatin LAR 30mg Injection
Oncology medicines should be administered strictly under medical supervision. Inform your oncologist immediately if you experience adverse symptoms.
Clinical Safety Advice for Sandostatin LAR 30mg Injection
Follow expert clinical guidelines regarding interactions, precautions, and medical conditions when taking Sandostatin LAR 30mg Injection.
It is not known whether it is safe to consume alcohol with Sandostatin LAR 30mg Injection. Please consult your doctor.
Sandostatin LAR 30mg Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Sandostatin LAR 30mg Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Sandostatin LAR 30mg Injection does not usually affect your ability to drive.
Sandostatin LAR 30mg Injection is safe to use in patients with kidney disease. No dose adjustment of Sandostatin LAR 30mg Injection is recommended.
Sandostatin LAR 30mg Injection should be used with caution in patients with liver disease. Dose adjustment of Sandostatin LAR 30mg Injection may be needed. Please consult your doctor.
Cold-Chain Temperature Protocol
Temperature-controlled cold-chain dispatch for Sandostatin LAR 30mg Injection across India, with express delivery in Delhi NCR, Noida, and Ghaziabad.
Temperature Monitoring
Sourced from certified cold-storage warehouses.
Insulated Transit
Dispatched in gel-ice thermal insulated boxes.
Rx Verification
Prescription validated prior to cold dispatch.
Frequently Asked Questions
Clinical Overview: Sandostatin LAR 30mg Injection
Sandostatin LAR 20mg Injection contains Octreotide, a long-acting somatostatin analog. Manufactured by Novartis, it is a specialized prescription medication used to manage specific types of hormone-producing neuroendocrine tumors as well as symptoms associated with acromegaly.
How It Works (Mechanism of Action)
Sandostatin LAR works by mimicking somatostatin, a natural hormone in the body that helps regulate and shut down the overproduction of various other hormones (like growth hormone or serotonin). By slowing down excessive hormone secretion, it helps control severe symptoms like flushing and diarrhea, while also helping to inhibit tumor growth in neuroendocrine conditions.
Therapeutic & Treatment Context
Oncologists and endocrinologists prescribe Sandostatin LAR for patients with neuroendocrine tumors (NETs) of the gut, pancreas, or pituitary gland, as well as for long-term maintenance treatment in acromegaly patients where surgery or radiation has not worked fully.
Important Clinical Information & Precautions
Sandostatin LAR is a deep intramuscular injection that must be administered strictly by a healthcare professional in a clinic or hospital setting. Because it affects hormone balance, your doctor will routinely monitor your gallbladder function, thyroid levels, and blood sugar levels during your treatment course.
Storage & Safe Handling Instructions
This medication requires strict cold-chain management. It must be stored in a refrigerator between 2°C and 8°C (36°F to 46°F). Do not freeze. It should be brought to room temperature just prior to reconstitution and administration by your medical professional.
Dosage & Administration Guidelines
Sandostatin LAR is a slow-release suspension given as a deep intramuscular injection into the gluteal muscle, typically administered once every 4 weeks by a trained nurse or doctor. It cannot be self-administered or given intravenously.
Authoritative References & Medical Sources
- FDA Prescribing Information for Sandostatin LAR (Octreotide)US FDAView Source
- NCCN Clinical Practice Guidelines in Oncology: Neuroendocrine and Adrenal TumorsNCCNView Source
Medical information standards
Educational product information for Sandostatin LAR 30mg Injection. Not a substitute for advice from your treating doctor or healthcare provider.
- Reviewed by
- Nitin Kumar, D.Pharm (UPPC Reg: 63405)Lead Registered Pharmacist · 11 years clinical experience · Drug licence RLF21DL2025001406, RLF20DL2025001420. See our medical review policy.
- Content dates
- Catalogue copy is re-checked under our editorial standards. Pricing and stock update more often at checkout.
- Business address
- Vyloo Technologies Pvt. Ltd.
10251, F/F, Library Road, Nawab Ganj, Delhi G.P.O., Delhi, North Delhi- 110006, Delhi, IndiaGSTIN 07AAKCV0933E1ZF, 09AAKCV0933E1ZB. More on our drug licence page.
Authoritative references
- CDSCO (India) — Central Drugs Standard Control Organisation — Indian drug regulator
- Ministry of Health & Family Welfare — Government of India health ministry
- WHO Essential Medicines — World Health Organization essential medicines lists
- National Health Portal (India) — Government of India National Health Portal
Have questions about your cancer prescription?
Our licensed oncology pharmacists are available to assist with medicine availability, cold-chain handling, and prescription verification.